| Project/Area Number |
06304032
|
|---|
| Research Category |
Grant-in-Aid for Co-operative Research (A)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | OSAKA UNIVERSITY |
|---|
Principal Investigator |
INOUE Toshihiko Osaka Univ., Medical School, Professor, 医学部, 教授 (70028512)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SUZUKI Norio Tokyo Univ., Medical School, Professor, 医学部, 教授 (10010050)
NAKANO Masao Ryukyu Univ., Medical School, Professor, 医学部, 教授 (80155788)
YAMASHITA Takashi Cancer Institute Hospital, Dept.of Radiotherapy, Cheaf of Radiotherapy, 放射線治療科, 部長 (70110939)
MASUDA Koji Kyusyu Univ., Medical School, Professor, 医学部, 教授 (10037377)
NOMURA Taisei Osaka Univ., Medical School, Professor, 医学部, 教授 (90089871)
|
|---|
| Project Period (FY) |
1994 – 1995
|
| Project Status |
Completed (Fiscal Year 1995)
|
| Budget Amount *help |
¥12,200,000 (Direct Cost: ¥12,200,000)
Fiscal Year 1995: ¥4,800,000 (Direct Cost: ¥4,800,000)
Fiscal Year 1994: ¥7,400,000 (Direct Cost: ¥7,400,000)
|
|---|
| Keywords | HIGH DOSE RATE FRACTIONATED RADIATION / LOW DOSE RATE CONTINUOUS RADIATION / BRACHYTHERAPY / HDR / LDR / 低線量率分割照射 |
|---|
| Research Abstract |
To investigate the high dose rate fractionated interstitial radiation (F-HDR) as an alternative to low dose rate continuous interstitial radiation (C-LDR), following studies were carried out.
1) Theoretical investigation using LQ model for the F-HDR in uneven fractionation and uneven interval was carried out. Using LQ model, Nominal standard effect was calculated for F-HDR.For late effect, 70 Gy/7 days were considered as the tolerance dose in the former studies. However, 70 Gy was the standard treatment dose, and 84 Gy was considered as the tolerance does in this study. Accoding to this change, for the tumor LQ model had the same result of the clinical data. However, for the late effect, alpha/beta must be considered as more than 3 that was used in the previous srudies.
2) Biological study using colony formation assay for SQ5 cell revealed the relative biological effectiveness (HDR/LDR,RBE_<H/L>) of 0.77. Spheroid cells showed the relatively radioresistance at 37ﾟC.According to the data of the SCD50 (50% spheroid cure dose) , the RBE_<H/L> of the spheroid cells was calculated as 0.87. This value was almost the same of the clinical data of the early tongue cancer (60 Gy in F-HDR vs 70 Gy in C-LDR) . In F-HDR radiation, RBE was decided only by total dose. Modification of the total dose was not needed in the different fractionations for F-HDR.
3) We carried out the randomized clinical trial of the F-HDR vs C-LDR for the patients with the early tongue cancer. patients were treated with 70 Gy/1 week in C-LDR group and with 60 Gy/10 fractions/6 days in F-HDR.Local recurrence occurred in 2 of 15 patients treated with C-LDR,and in none of 13 patients treated with F-HDR.This clinical trial also revealed that 70 Gy of the F-HDR was almost the same as 60 Gy of C-LDR.The theoretical model, biological study and clinical study showed the same results. We concluded the F-HDR is an alternative to C-LDR.
|
